Walsh & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Walsh & Associates's AMGN Position: Q3 2026 in Review
Walsh & Associates held its Amgen (AMGN) position steady in Q3 2026 at 250 shares worth $105K. The position accounts for 0.08% of the portfolio, ranked #85.
Walsh & Associates first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Walsh & Associates held 250 shares of Amgen worth $105K as of Q3 2026.
- Walsh & Associates left its Amgen share count unchanged in Q3 2026.
- Amgen made up 0.08% of Walsh & Associates's portfolio in Q3 2026, its #85 holding.
- Walsh & Associates first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
- 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.